BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

TEAD1 identified as target in a gastric cancer subtype

By Claire Quang, Staff Writer
August 27, 2021 8:54 PM UTC

DISEASE CATEGORY: Cancer

INDICATION: Gastric cancer...

BCIQ Company Profiles

Japanese National Cancer Center

BCIQ Target Profiles

MAP kinase kinase 1 (MAP2K1) (MEK1)

MAP kinase kinase 2 (MAP2K2) (MEK2)

TEA domain family member 1 (TEAD1)

BCIQ Company Profiles

Japanese National Cancer Center

BCIQ Target Profiles

MAP kinase kinase 1 (MAP2K1) (MEK1)

MAP kinase kinase 2 (MAP2K2) (MEK2)

TEA domain family member 1 (TEAD1)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS